Suit Alleges Conspiracy Among Drug Cos., Wholesalers

Law360, New York (July 20, 2006, 12:00 AM EDT) -- A Long Island-based drug wholesaler is targeting 16 pharmaceutical companies in a federal antitrust suit that seeks damages in excess of $2.3 billion and makes sweeping claims about anticompetitive conduct in the pharmaceutical industry.

RxUSA Wholesale Inc.’s 167-page complaint, filed in the U.S. District Court for the Eastern District of New York, contains 23 counts, and alleges that the defendants—which include Sanofi-Aventis, Schering-Plough, Wyeth, Merck and Pfizer, as well as five drug wholesalers—are colluding to smother competition.

The complaint also claims that certain defendants violated federal...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.